>
>
Clinical Trial Imaging Market Size - By Service (Clinical Trial Design & Consultation Services), Imaging Technique, Therapeutic Area, End-user, Global Forecast 2023-2032
Download Free PDF

Clinical Trial Imaging Market
Get a free sample of this reportGet a free sample of this report Clinical Trial Imaging Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 13
Tables & Figures: 290
Countries covered: 21
Pages: 170
Download Free PDF
Clinical Trial Imaging Market Size
Clinical Trial Imaging Market size was around USD 1.1 billion in 2022 and is expected to reach USD 2.4 billion by 2032 due to the increasing demand for novel products to treat chronic disorders. upsurge in R&D investment and activities, increasing number of clinical trials. For instance, according to ClinicalTrials.gov 2023, there are 452,604 clinical trials registered worldwide, with 64,838 actively recruiting participants. This marks a substantial increase from the approximately 365,000 trials recorded in 2021.
Clinical trial imaging is the process of using advanced medical imaging techniques, such as MRI, CT scans, PET scans, and X-rays, to evaluate the effectiveness and safety of new medical treatments, drugs, or medical devices. It involves the acquisition, analysis, and interpretation of medical images to assess the impact of a treatment on a patient's condition. Clinical trial imaging is crucial in drug development, allowing researchers to visualize disease progression, treatment responses, and potential side effects, aiding in the development of new healthcare solutions.
COVID-19 Impact
The COVID-19 pandemic posed a significant challenge such as delays in ongoing studies and the cancellation of planned trials. Also, regulatory adjustments, supply chain interruptions, recruitment obstacles, concerns about viral transmission, and the shutdown of manufacturers have all negatively affected clinical research. However, the pandemic had also prompted the emergence of virtual trials, offering new prospects. For instance, as per the study in the American Journal of Roentgenology (AJR) suggests that virtual imaging trials, combined with the assessment and improvement of CT and radiography acquisitions through various analytical tools, hold promise for aiding in the management of the pandemic.
Clinical Trial Imaging Market Trends
Clinical Trial Imaging Market Analysis
Based on service, the market is segmented into clinical trial design and consultation services, reading and analytical services, operational imaging, system & technology support services and project and data management. The project & data management services held the largest market share at 32.8% in 2022.
Based on imaging techniques, the global clinical trial imaging market is classified into magnetic resonance imaging (MRI), computed tomography (CT) scan, ultrasound, positron emission tomography (PET), echocardiography (ECG), X-ray and other imaging techniques. The magnetic resonance imaging (MRI) segment is expected to reach USD 649.7 million by the end of 2032.
Based on therapeutic area, the clinical trial imaging market is segmented into central nervous system, oncology, infectious disease, endocrinology & metabolic disorders, diabetes, musculoskeletal, cardiovascular diseases, respiratory, gastroenterology, non-alcoholic steatohepatitis (NASH) and other therapeutic areas.
Based on the end users, the clinical trial imaging market is segmented into biotechnology & pharmaceutical companies, medical devices manufacturers, contract research organization (CRO), academics & government research institutes, and other end users.
In 2022, North America held a significant share of 40.3% in the clinical trial imaging market.
Clinical Trial Imaging Market Share
The Clinical Trial Imaging industry exhibits moderate competition and features numerous prominent players. Notable players include ICON PLC, Medpace, WCG Clinical, Radiant Sage and Ixico PLC among others. These players employ a strategy such as continuous innovation in imaging technology, worldwide expansion, data security to secure a significant share in the market.
Prominent market players operating in the industry is as mentioned below:
Clinical Trial Imaging Industry News:
The clinical trial imaging market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Service, 2018 – 2032 (USD Million)
By Imaging Technique, 2018 – 2032 (USD Million)
By Therapeutic Area, 2018 – 2032 (USD Million)
By End user, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries: